578P Increased therapeutic index of muzastotug (ADG126), a masked anti-CTLA-4 antibody, in combination with pembrolizumab (pembro) enables significant clinical benefits and support... von Li, D., Kim, S.Y., Kim, H.K., Sharma, S., Shin, S.J., Lee, J., Im, S-A., She, X.K., Li, Y., Chung, L.E.C., Xiao, P., Liu, G., Zeng, S., HuLowe, D., Chisamore, M., Luo, P.P., Zha, J., Patel, M.R.

Volltext